An international team led by a University of Pittsburgh School of Medicine scientist has created a first-of-its-kind resource ...
PITTSBURGH - An international team led by a University of Pittsburgh School of Medicine scientist has created a first-of-its-kind resource to identify ...
Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...
AI-powered vector design and preclinical validation mark the first step in a multi-phase program aimed at accelerating the path from discovery to clinical assessment in Alzheimer's disease. AUSTIN, TX ...
Synthekine Inc., an engineered cytokine therapeutics company, today announced that data from a Phase 1a/1b clinical trial of its ?/? biased IL-2 partial agonist, STK-012, will be presented in a ...
Scientists have identified hundreds of genes that may increase the risk of developing Alzheimer's disease but the roles these genes play in the brain are poorly understood.
Q3 2025 Earnings Call Transcript October 28, 2025 Operator: Thank you for standing by. At this time, I would like to welcome ...
With a newly developed method that compares AI-generated protein sequences with naturally occurring ones, function- and ...
As firms increasingly invest in OB-GYN practices, fertility clinics, maternity care services, and other health care ...